Search for: "Mylan Pharmaceuticals"
Results 481 - 500
of 739
Sorted by Relevance
|
Sort by Date
24 Dec 2008, 3:00 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Classen v Biogen (not precedential): Federal Circuit applies Bilski to the life sciences (Holman's Biotech IP Blog) (Inventive Step) (Hal Wegner) (EFF) (Patently-O) (Patent Prospector) (The Fire of Genius) (Patent Baristas) (Managing Intellectual Property) (Patent Docs) (Spicy IP) General India: Investing farmers with IP… [read post]
15 Mar 2015, 6:18 pm
The proposed bill reflects a basic misunderstanding of the pharmaceutical marketplace, and attempts to impose brand pharmaceutical provisions on generic drugs. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
6 Apr 2011, 12:18 am
Highlights this week included: India firm on ‘NO’ to data exclusivity (SiNApSE) (Generic Pharmaceuticals and IP) (Spicy IP) (Spicy IP) US: CAFC hears oral arguments on patentability of DNA claims: American Molecular Pathology, et. al, v. [read post]
16 Jan 2011, 9:48 pm
The manufacturers that filed the appeals case were: Teva Pharmaceutical Industries, Mylan Inc.'s UDL Laboratories and Actavis Inc. [read post]
3 Oct 2022, 8:27 am
Mylan Pharmaceuticals Inc., No. 21-1567 [read post]
23 Jan 2019, 10:08 am
Mylan Pharmaceuticals, Inc., et al. [read post]
13 Sep 2019, 11:09 am
Mylan Pharmaceuticals Inc., 896 F.3d 1332 (Fed. [read post]
19 Oct 2010, 10:42 pm
General WTO paragraph 6 meeting aims at improved use of health waiver (IP Watch) The absence of investment in new antibiotics (IPBiz) Integration of intellectual property and regulatory exclusivity strategies for life science companies (IP Spotlight) Pharmaceutical companies can innovate if they want to (profitability through simplicity) Medicines Patent Pool seeks business director (IP Watch) WHO moves IP, innovation out of Director General’s office (IP Watch) A rights-poor… [read post]
18 Sep 2019, 6:35 am
District Court in Connecticut alleges Teva, Pfizer, Mylan, and 17 other pharmaceutical companies worked in tandem to create a ‘fair share’ of the generic drug market and avoid price-lowering competition. [read post]
21 Sep 2011, 2:36 am
USPTO (Patent Docs) US: Deciphering the patent-eligibility message in Prometheus, Myriad and Classen (Patent Docs) US: Biotech/pharma patent issuances increased 39% in 2010 (Patent Docs) Vietnam cables: Data exclusivity should be automatic, comprehensive, retroactive and without procedures and formalities (KEI) Products Actos (Pioglitazone) – US: Takeda files patent infringement complaint against Accord Healthcare in response to Para IV certification (Patent Docs) Atorvastatin –… [read post]
28 Dec 2009, 7:57 am
The case is still proceeding against Dey, Inc., Mylan Pharmaceuticals, Inc., Sandoz, Inc. and their parent companies. [read post]
25 Aug 2010, 12:37 am
Torrent Pharmaceuticals Ltd. et al. [read post]
29 Jun 2011, 3:34 am
Sagent Pharmaceuticals, Inc. et al. [read post]
13 Jul 2011, 3:04 am
(The SPC Blog) Doha+10: On November 14, 2011, a meeting at WIPO in Geneva to discuss the Doha Declaration (KEI) Docs at BIO: Session on IP challenges for personalised medicine (Patent Docs) France to reform its pharmaceutical regulatory system… with possible global implications! [read post]
15 Apr 2010, 4:27 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/ Highlights this week included: CAFC denies Vanderbilt’s claim to Cialis patent right: Vanderbilt University v ICOS Corporation (Patently-O) (IPBiz) Paris District Court: Basic patent for Losartan covers any product comprising Losartan: Du Pont v Mylan Losartan SPC case (EPLAW) General WHO documents from counterfeit meeting now online (IP… [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
10 Feb 2010, 4:47 pm
Mylan Pharmaceuticals Inc. [read post]
9 Sep 2010, 7:09 pm
Zenith Goldline Pharmaceuticals, Inc., 471 F.3d 1369, 1377-79 (Fed. [read post]
